Efficacy of coronavirus disease 2019 vaccines in patients with rheumatic diseases

OBJECTIVES: In this study, we report the immune response to the BNT162b2 vaccine and CoronaVac vaccine after a two-dose vaccination and the effects of conventional drugs, immunosuppressive drugs, and new-generation therapies on vaccine responses in patients with rheumatic and musculoskeletal disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Taştekin, Fatih, Taşbakan, Meltem, Çiçek, Candan, Soylu, Mehmet, Yargucu Zihni, Figen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish League Against Rheumatism 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689018/
https://www.ncbi.nlm.nih.gov/pubmed/38046249
http://dx.doi.org/10.46497/ArchRheumatol.2023.9676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689018/
https://www.ncbi.nlm.nih.gov/pubmed/38046249
http://dx.doi.org/10.46497/ArchRheumatol.2023.9676

Ejemplares similares